CIK 0001087294
- Non-accelerated filer
- Smaller reporting company
CUMBERLAND PHARMACEUTICALS INC
Sign in to watch- Ticker
- CPIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TN
- Entity type
- Operating
- EIN
- 621765329
- Phone
- +1 615-255-0068
- Business address
- 1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
- 4 Grant or award Director acquired 4,000 shares (grant or award)
- 4 Open-market sale Director sold 8,000 shares at $6.97 ($55,760)
- 4 Open-market buy Chief Financial Officer bought 300 shares at $6.95 ($2,085)
- 4 Grant or award Director acquired 2,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Open-market sale Director sold 6,000 shares at $6.40 ($38,400)
- 4 Grant or award Sr VP/Chief Commercial Officer acquired 11,600 shares (grant or award)
- 4 Grant or award VP and Chief Compliance Office acquired 6,000 shares (grant or award)
- 4 Grant or award Chairman and CEO acquired 100,000 shares (grant or award)
- 4 Grant or award SVP and Chief Development Off. acquired 10,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 2,500 shares (grant or award)
- 4 Open-market buy Chief Financial Officer bought 900 shares at $6.42 ($5,778)
- 4 Open-market buy Director bought 15,000 shares at $6.53 ($97,950)
- 4 Open-market sale Director sold 20,781 shares at $6.24 ($129,673)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 18,600 shares at $5.07 ($94,302)
Page 18 of 26 · 512 filings